📊 DROR Key Takeaways
Is Dror Ortho-Design, Inc. (DROR) a Good Investment?
Dror Ortho-Design faces severe financial distress with negative stockholders' equity of -2.9M, indicating the company is technically insolvent. Despite revenue growth of 156.8% YoY, the company remains unprofitable with -2.5M net loss and negative operating cash flow of -2.1M, suggesting the revenue growth is not sustainable or translating to operational viability. The company's liquidity crisis (0.08x current ratio) combined with liabilities exceeding assets by 2.8M leaves minimal margin for error.
Dror Ortho-Design, Inc. shows severe fundamental weakness: revenue is effectively negligible at $2.57K while losses remain in the multi-million-dollar range, producing deeply negative operating and net margins. The balance sheet is distressed, with negative equity, a current ratio of just 0.08x, and persistent negative operating cash flow, indicating the business is not currently self-sustaining and likely dependent on external financing.
Why Buy Dror Ortho-Design, Inc. Stock? DROR Key Strengths
- Year-over-year revenue growth of 156.8% shows demand for products
- Cash reserves of 228.5K provide short-term operational runway
- Operating loss improved from prior year (net loss up 55.9% YoY, though still negative)
- Revenue grew 156.8% year over year, indicating some top-line activity improvement from a very small base
- Cash of $228.54K provides limited near-term liquidity relative to asset size
- Net loss improved year over year, suggesting losses narrowed from the prior period
DROR Stock Risks: Dror Ortho-Design, Inc. Investment Risks
- Negative stockholders' equity of -2.9M indicates technical insolvency and bankruptcy risk
- Operating cash flow of -2.1M exceeds revenue by 808x, demonstrating operational cash burn unsustainable at current scale
- Current ratio of 0.08x represents severe liquidity crisis with liabilities 12.5x current assets
- Negative operating margin of -86,565% and net margin of -99,100% reveal business model dysfunction
- No insider buying activity in last 90 days suggests lack of management confidence
- Total liabilities (3.1M) exceed total assets (258.9K) by 1,100%, creating covenant violation risk
- Revenue base is immaterial relative to the cost structure, resulting in extreme negative margins and poor growth quality
- Negative stockholders equity and liabilities far exceeding assets indicate balance-sheet distress
- Operating cash burn of $2.06M with a 0.08x current ratio points to substantial liquidity and going-concern risk
Key Metrics to Watch
- Quarterly cash burn rate and path to cash runway depletion
- Whether revenue growth sustains or reverses as cash constraints tighten
- Changes in stockholders' equity and whether company achieves GAAP profitability
- Quarterly revenue growth versus operating expense trend
- Cash runway, operating cash flow, and any improvement in working capital or equity position
Dror Ortho-Design, Inc. (DROR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
DROR Profit Margin, ROE & Profitability Analysis
DROR vs Healthcare Sector: How Dror Ortho-Design, Inc. Compares
How Dror Ortho-Design, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Dror Ortho-Design, Inc. Stock Overvalued? DROR Valuation Analysis 2026
Based on fundamental analysis, Dror Ortho-Design, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Dror Ortho-Design, Inc. Balance Sheet: DROR Debt, Cash & Liquidity
DROR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Dror Ortho-Design, Inc.'s revenue has grown significantly by 157% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
DROR Revenue Growth, EPS Growth & YoY Performance
DROR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2022 | $913 | -$27.2K | $0.00 |
| Q2 2022 | $460 | -$36.9K | $0.00 |
| Q1 2022 | $1.2K | -$47.5K | $0.00 |
| Q3 2021 | $913 | -$27.2K | N/A |
| Q2 2021 | $460 | -$31.6K | N/A |
| Q1 2021 | $1.0K | -$47.5K | N/A |
| Q3 2020 | $1.0K | -$34.4K | N/A |
| Q2 2020 | $1.0K | -$26.7K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Dror Ortho-Design, Inc. Dividends, Buybacks & Capital Allocation
DROR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Dror Ortho-Design, Inc. (CIK: 0001282980)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DROR
What is the AI rating for DROR?
Dror Ortho-Design, Inc. (DROR) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DROR's key strengths?
Claude: Year-over-year revenue growth of 156.8% shows demand for products. Cash reserves of 228.5K provide short-term operational runway. ChatGPT: Revenue grew 156.8% year over year, indicating some top-line activity improvement from a very small base. Cash of $228.54K provides limited near-term liquidity relative to asset size.
What are the risks of investing in DROR?
Claude: Negative stockholders' equity of -2.9M indicates technical insolvency and bankruptcy risk. Operating cash flow of -2.1M exceeds revenue by 808x, demonstrating operational cash burn unsustainable at current scale. ChatGPT: Revenue base is immaterial relative to the cost structure, resulting in extreme negative margins and poor growth quality. Negative stockholders equity and liabilities far exceeding assets indicate balance-sheet distress.
What is DROR's revenue and growth?
Dror Ortho-Design, Inc. reported revenue of $2.6K.
Does DROR pay dividends?
Dror Ortho-Design, Inc. does not currently pay dividends.
Where can I find DROR SEC filings?
Official SEC filings for Dror Ortho-Design, Inc. (CIK: 0001282980) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DROR's EPS?
Dror Ortho-Design, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DROR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Dror Ortho-Design, Inc. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DROR stock overvalued or undervalued?
Valuation metrics for DROR: ROE of N/A (sector avg: 15%), net margin of -99,100.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DROR stock in 2026?
Our dual AI analysis gives Dror Ortho-Design, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DROR's free cash flow?
Dror Ortho-Design, Inc.'s operating cash flow is $-2.1M, with capital expenditures of $966.0. FCF margin is -80,179.6%.
How does DROR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -99,100.0% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.08 (avg: 2).